ImmuneXcite Garners $8,600,000 Series A Financing Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    3 Forbes Road Lexington, MA 02421 USA
  • Company Description
    ImmuneXcite has developed a proprietary platform technology for enhancing the efficacy of therapeutic monoclonal antibodies for oncological and infectious disease targets.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    ImmuneXcite plans to use the funding to complete studies that will enable selection of a lead program to advance into clinical trials.
  • M&A Terms
  • Venture Investor
    Cormorant Asset Management
  • Venture Investor
    Sanofi-Genzyme BioVentures
  • Venture Investor
    Partners Innovation Fund

Trending on Xconomy